Fig. 2From: Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancerWaterfall Graph of Percentage Change. Waterfall plot analysis showed that most patients (83.3%) exhibited a decrease in tumour size. Waterfall graph of the percentage change in total sum of the target lesion diameters from baseline to post-baseline nadir (RECIST 1.1). Abbreviation: RECIST = Response Evaluation Criteria in Solid TumoursBack to article page